France Neurology Clinical Trials Market Analysis

France Neurology Clinical Trials Market Analysis


$ 3999

The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The market will be driven by the growing frequency of neurological diseases and the robust research infrastructure of France. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Sanofi SA & Neuraxpharm France SAS.

ID: IN10FRCT005 CATEGORY: Clinical Trials GEOGRAPHY: France AUTHOR: Vidhi Upadhyay

Buy Now

France Neurology Clinical Trials Market Executive Summary

The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The universal hybrid healthcare system in France is regarded as one of the best in the world, providing high-quality medical treatment. Healthcare expenditures in France are borne by both the state and the individual. In 2020, healthcare spending in France was comparable to 12.2% of GDP, greater than in any other EU Member State. Over 1,175,000 individuals in France have Alzheimer's disease, and over 200,000 more are identified with Alzheimer's or another dementia each year. France was the first European country to adopt a national Alzheimer's disease strategy.

Neurology clinical trials are a significant area of study in France, with several top pharmaceutical firms and research organisations undertaking studies in this subject. The French government has also aggressively promoted clinical research, with projects such as the French Clinical Trials Infrastructure Network (F-CRIN) aimed at bolstering the country's status as a clinical research centre. In recent years, there has been a greater emphasis on creating therapies for neurological illnesses such as Alzheimer's, Parkinson's, and multiple sclerosis, which has resulted in an increase in neurology clinical trials in France. According to ClinicalTrials.gov, there are now over 1,500 active clinical studies in France, with many of them focusing on neurology.

France Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

The expanding elderly population, as well as the frequency and incidence of nerve-related ailments among them, propels the neurological clinical trials market forward. The growing frequency of neurological diseases, as well as the high number of nerve injuries, demands the establishment of a neurology clinical trials industry. France has a robust research infrastructure, with a huge pool of qualified researchers and excellent facilities which is why market participants and researchers are increasingly focusing on expanding neurostimulation and neuromodulation technologies such as next-generation neurostimulation devices, firm collaborations to introduce enhanced products, and the forthcoming newest innovations. Government financing for neurological disease research hastened market expansion, which is expected to drive market growth.

Market Restraints

The clinical trial regulatory environment in France is complicated, with strong restrictions and criteria for ethical and safety issues. This might make it tough for firms to launch and perform clinical studies in the nation. Clinical trials are expensive and need substantial finance, which can be difficult for smaller businesses or research organisations with few resources. Other nations, such as the United States and China, are also actively investing in clinical research and recruiting major pharmaceutical corporations and research institutes posing good competition.

Competitive Landscape

Global Key Players

  • Pfizer Inc.
  • Novartis International AG
  • Sanofi SA
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Biogen Inc.
  • Roche Holding AG
  • Eli Lilly and Company
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.

Local Key Players

  • BrainVectis - is dedicated to the research and development of medicines for neurodegenerative disorders such as Huntington's and Alzheimer's
  • Ipsen - is a worldwide, mid-sized biopharmaceutical firm dedicated to developing breakthrough therapies in cancer, rare diseases, and neurology
  • LFB Biotechnologies - LFB is a biopharmaceutical business that researches, produces, and sells plasma-derived medical products and recombinant proteins for the treatment of patients suffering from severe and usually rare diseases
  • BioSerenity - is a cutting-edge medical technology firm that specialises in smart healthcare solutions for Sleep Medicine, Neurology, and Cardiology
  • Neuraxpharm France SAS - is a renowned European specialized pharmaceutical firm focusing on the treatment of illnesses of the central nervous system (CNS)

Notable Insights

August 2022, The National Agency for the Safety of Medicines and Health Products (ANSM) in France has authorized BrainVectis permission to begin enrolling patients for a phase 1/2 clinical study of their experimental adeno-associated virus (AAV) gene therapy for the treatment of early-stage Huntington illness.

Healthcare Policies and Regulatory Landscape & Reimbursement Scenario

Clinical trials are monitored in France by the French National Agency for Medical and Health Products Safety (ANSM) and the French Committee for the Protection of Persons (CPP). The ANSM is in charge of assessing, monitoring, and regulating pharmaceutical goods, whereas the CPP is in charge of ethical assessment and approval of clinical studies involving human subjects.

Neurology clinical trials in France are primarily financed by pharmaceutical firms or academic institutions, and they must adhere to the ANSM and CPP criteria. The ANSM examines the treatment's safety and efficacy and authorises the study before it can begin, whereas the CPP reviews the trial protocol and assures that it fulfils ethical and legal criteria.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up